Intuitive Surgical, Inc. Capital Expenditures Incurred but Not yet Paid
Intuitive Surgical, Inc. (ISRG) reported Capital Expenditures Incurred but Not yet Paid of $68.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-21
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $3.60M.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $65.20M, a 33.33% decline year-over-year.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$9.30M.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $5.10M, a 52.34% decline year-over-year.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $70.60M, a 8.55% decline from fiscal 2024.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $77.20M, a 49.77% decline from fiscal 2023.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $153.70M, a 109.40% increase from fiscal 2022.
- Intuitive Surgical, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $73.40M, a 128.66% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $68.80M 10-Q · filed 2026-07-21 | $59.50M derived: sum of 3 quarters · filed 2026-07-21 | $64.60M derived: sum of 4 quarters · filed 2026-07-21 |
| 2026-03-31 | $65.20M 10-Q · filed 2026-04-22 | $55.90M derived: sum of 2 quarters · filed 2026-04-22 | $61.00M derived: sum of 3 quarters · filed 2026-04-22 | $38.00M derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-12-31 | -$9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | -$4.20M derived: sum of 2 quarters · filed 2026-02-03 | -$27.20M derived: sum of 3 quarters · filed 2026-07-21 | $70.60M 10-K · filed 2026-02-03 |
| 2025-09-30 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | -$17.90M derived: sum of 2 quarters · filed 2026-07-21 | $79.90M 10-Q · filed 2025-10-22 | -$37.80M derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-06-30 | -$23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $74.80M 10-Q · filed 2026-07-21 | -$42.90M derived: sum of 3 quarters · filed 2026-07-21 | -$32.20M derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-03-31 | $97.80M 10-Q · filed 2026-04-22 | -$19.90M derived: sum of 2 quarters · filed 2026-04-22 | -$9.20M derived: sum of 3 quarters · filed 2026-04-22 | -$2.90M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | -$117.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | -$107.00M derived: sum of 2 quarters · filed 2026-02-03 | -$100.70M derived: sum of 3 quarters · filed 2026-02-03 | $77.20M 10-K · filed 2026-02-03 |
| 2024-09-30 | $10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $17.00M derived: sum of 2 quarters · filed 2025-10-22 | $194.90M 10-Q · filed 2025-10-22 | $213.40M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $184.20M 10-Q · filed 2025-07-23 | $202.70M derived: sum of 3 quarters · filed 2026-02-03 | $199.70M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $177.90M 10-Q · filed 2025-04-23 | $196.40M derived: sum of 2 quarters · filed 2026-02-03 | $193.40M derived: sum of 3 quarters · filed 2026-02-03 | $251.40M derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $15.50M derived: sum of 2 quarters · filed 2026-02-03 | $73.50M derived: sum of 3 quarters · filed 2026-02-03 | $153.70M 10-K · filed 2026-02-03 |
| 2023-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-18 | $55.00M derived: sum of 2 quarters · filed 2024-10-18 | $135.20M 10-Q · filed 2024-10-18 | $117.20M derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-06-30 | $58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19 | $138.20M 10-Q · filed 2024-07-19 | $120.20M derived: sum of 3 quarters · filed 2025-01-31 | $115.80M derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-03-31 | $80.20M 10-Q · filed 2024-04-19 | $62.20M derived: sum of 2 quarters · filed 2025-01-31 | $57.80M derived: sum of 3 quarters · filed 2025-01-31 | $100.10M derived: sum of 4 quarters · filed 2025-01-31 |
| 2022-12-31 | -$18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | -$22.40M derived: sum of 2 quarters · filed 2025-01-31 | $19.90M derived: sum of 3 quarters · filed 2025-01-31 | $73.40M 10-K · filed 2025-01-31 |
| 2022-09-30 | -$4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-20 | $37.90M derived: sum of 2 quarters · filed 2023-10-20 | $91.40M 10-Q · filed 2023-10-20 | $93.60M derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-06-30 | $42.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-24 | $95.80M 10-Q · filed 2023-07-24 | $98.00M derived: sum of 3 quarters · filed 2024-01-31 | $113.60M derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-03-31 | $53.50M 10-Q · filed 2023-04-20 | $55.70M derived: sum of 2 quarters · filed 2024-01-31 | $71.30M derived: sum of 3 quarters · filed 2024-01-31 | $58.00M derived: sum of 4 quarters · filed 2024-01-31 |
| 2021-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $17.80M derived: sum of 2 quarters · filed 2024-01-31 | $4.50M derived: sum of 3 quarters · filed 2024-01-31 | $32.10M 10-K · filed 2024-01-31 |
| 2021-09-30 | $15.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $2.30M derived: sum of 2 quarters · filed 2022-10-21 | $29.90M 10-Q · filed 2022-10-21 | $33.10M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | -$13.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $14.30M 10-Q · filed 2022-07-22 | $17.50M derived: sum of 3 quarters · filed 2023-02-10 | $27.60M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $27.60M 10-Q · filed 2022-04-22 | $30.80M derived: sum of 2 quarters · filed 2023-02-10 | $40.90M derived: sum of 3 quarters · filed 2023-02-10 | $24.90M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $13.30M derived: sum of 2 quarters · filed 2023-02-10 | -$2.70M derived: sum of 3 quarters · filed 2023-02-10 | $47.30M 10-K · filed 2023-02-10 |
| 2020-09-30 | $10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$5.90M derived: sum of 2 quarters · filed 2021-10-20 | $44.10M 10-Q · filed 2021-10-20 | |
| 2020-06-30 | -$16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | $34.00M 10-Q · filed 2021-07-21 | ||
| 2020-03-31 | $50.00M 10-Q · filed 2021-04-21 | |||
| 2019-12-31 | $30.20M 10-K · filed 2022-02-03 | |||
| 2018-12-31 | $21.70M 10-K · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |